You are here

Consortia to Accelerate Therapeutic Applications of Stem Cells - 2013

RFA #: 1212030210   


PI Amount Title
Icahn School of Medicine at Mount Sinai Ronald Hoffmann $8,782,529 Commercialization of Valproic Acid Expanded Cord Blood Stem Cells as Allogeneic Grafts for Adults with Refractory Hematological Malignancies
Roswell Park Cancer Institute Kunle Odunsi $11,922,885 Programing Hematopoetic Stem Cells for Long-Term Targeted T Cell Therapy of Patients with Relapsed Ovarian Cancer
Weill Cornell Medical College Shahin Rafii $15,717,575 Vascular Niche Platform to Expand Hematopoietic Stem and Progenitor Cells Engineered to Cure Sickle Cell Disease

Please visit the Developing Cures page for more information.